Cordycepin Regulates the Nrf2/Hmox1 Signaling Pathway to Inhibit Ferroptosis and Improve AKI‐CKD
6 affiliations
- 1Shanxi University of Chinese Medicine Third Clinical College Jinzhong Shanxi China
- 2Department of Nephrology Shanxi Provincial People's Hospital Taiyuan Shanxi China
- 3Department of Nephrology The Fifth Clinical Medical College of Shanxi Medical University Taiyuan Shanxi China
- 4Big Data Center of Kidney Disease Shanxi Provincial People's Hospital Taiyuan Shanxi China
- 5Shanxi Provincial Key Laboratory of Kidney Disease Taiyuan Shanxi China
- 6Medicinal Basic Research Innovation Center of Chronic Kidney Disease, Ministry of Education Shanxi Medical University Taiyuan Shanxi China
Abstract
Cordycepin (COR) exerts pharmacological effects in various diseases, yet its role in tissue repair following acute kidney injury (AKI) remains to be fully elucidated. This study aimed to investigate whether COR delays the progression from acute kidney injury to chronic kidney disease (AKI‐CKD) and to explore its underlying mechanisms. Network pharmacology was employed to identify shared targets among ferroptosis, AKI‐CKD, and COR using multiple databases. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed, followed by molecular docking validation. In vivo, a renal unilateral ischemia–reperfusion (uIRI) mouse model was established in C57Bl/6N mice (n = 20), randomly divided into four groups (n = 5 each): Control, CKD model, COR, and CKD + COR. COR (10 mg/kg) or saline was administered intraperitoneally daily for 2 weeks. Renal pathology and fibrosis were assessed via H&E, PAS, and Masson staining; renal function by serum creatinine and proteinuria. In vitro, HK‐2 cells were treated with H2O2 with or without COR, and cell viability was measured by CCK‐8. The Nrf2 inhibitor ML385 was used to verify pathway involvement. The mRNA and protein levels of GPX4, ACSL4, Nrf2, and Hmox1 were determined by qRT‐PCR and Western blot. Cross‐analysis of network pharmocology identified 42 common targets among 459 COR‐related, 843 AKI‐CKD‐related, and 1866 ferroptosis‐related genes. PPI network analysis suggested that TNF, IL6, and Hmox1 are key targets. Enrichment analyses indicated involvement in iron homeostasis and oxidative stress responses. Molecular docking revealed strong binding of COR to Nrf2 and Hmox1 (–8.5 and –6.7 kcal/mol). In vivo, model mice showed elevated serum creatinine and proteinuria, severe tubular damage, and increased fibrosis, all significantly ameliorated by COR. In vitro, H2O2 reduced HK‐2 cell viability, downregulated GPX4, Nrf2, and Hmox1, and upregulated ACSL4; COR reversed these effects and improved cell survival. ML385 partially blocked COR's protective and regulatory effects, confirming Nrf2/Hmox1 pathway dependence. Our finding indicated that COR inhibits ferroptosis via activation of the Nrf2/Hmox1 signaling pathway, thereby attenuating renal injury and fibrosis and slowing AKI‐CKD progression.
Related
- Curcumin carried by polystyrene nanoparticles inhibits phosphatidylinositol 3-kinase/protein kinase B signaling pathway through miR-186 and down-regulates Twist to inhibit the epithelial-mesenchymal transition in colorectal cancer in mice
- Fatostatin targets SCAP/SREBP pathway to inhibit ARID1A-deficient non-small cell lung cancer by promoting ferroptosis
- Integrated single-cell transcriptomics reveals miR-941 targets CLDN4 to inhibit malignant progression of thyroid cancer through the PI3K/AKT signaling pathway.
- Biochanin A suppresses ferroptosis after traumatic brain injury via the Nrf2/HO-1 signaling pathway
- The integrin αvβ6/TGF-β1/Smad4 signaling pathway regulates ENaC in alcohol induced ARDS
BibTeX
@article{xi2026cordycepin,
title = {{Cordycepin Regulates the Nrf2/Hmox1 Signaling Pathway to Inhibit Ferroptosis and Improve AKI‐CKD}},
author = {Luming Xi and Mengqi Bai and Junhu Li and Zhibo Zhao and Xiaoshuang Zhou},
journal = {Cell Biochemistry and Function},
year = {2026},
month = oct,
doi = {10.1002/cbf.70330},
url = {https://doi.org/10.1002/cbf.70330},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Cordycepin Regulates the Nrf2/Hmox1 Signaling Pathway to Inhibit Ferroptosis and Improve AKI‐CKD
AU - Luming Xi
AU - Mengqi Bai
AU - Junhu Li
AU - Zhibo Zhao
AU - Xiaoshuang Zhou
PY - 2026
DA - 2026/10/01
JO - Cell Biochemistry and Function
DO - 10.1002/cbf.70330
UR - https://doi.org/10.1002/cbf.70330
AB - Cordycepin (COR) exerts pharmacological effects in various diseases, yet its role in tissue repair following acute kidney injury (AKI) remains to be fully elucidated. This study aimed to investigate whether COR delays the progression from acute kidney injury to chronic kidney disease (AKI‐CKD) and to explore its underlying mechanisms. Network pharmacology was employed to identify shared targets among ferroptosis, AKI‐CKD, and COR using multiple databases. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed, followed by molecular docking validation. In vivo, a renal unilateral ischemia–reperfusion (uIRI) mouse model was established in C57Bl/6N mice (n = 20), randomly divided into four groups (n = 5 each): Control, CKD model, COR, and CKD + COR. COR (10 mg/kg) or saline was administered intraperitoneally daily for 2 weeks. Renal pathology and fibrosis were assessed via H&E, PAS, and Masson staining; renal function by serum creatinine and proteinuria. In vitro, HK‐2 cells were treated with H2O2 with or without COR, and cell viability was measured by CCK‐8. The Nrf2 inhibitor ML385 was used to verify pathway involvement. The mRNA and protein levels of GPX4, ACSL4, Nrf2, and Hmox1 were determined by qRT‐PCR and Western blot. Cross‐analysis of network pharmocology identified 42 common targets among 459 COR‐related, 843 AKI‐CKD‐related, and 1866 ferroptosis‐related genes. PPI network analysis suggested that TNF, IL6, and Hmox1 are key targets. Enrichment analyses indicated involvement in iron homeostasis and oxidative stress responses. Molecular docking revealed strong binding of COR to Nrf2 and Hmox1 (–8.5 and –6.7 kcal/mol). In vivo, model mice showed elevated serum creatinine and proteinuria, severe tubular damage, and increased fibrosis, all significantly ameliorated by COR. In vitro, H2O2 reduced HK‐2 cell viability, downregulated GPX4, Nrf2, and Hmox1, and upregulated ACSL4; COR reversed these effects and improved cell survival. ML385 partially blocked COR's protective and regulatory effects, confirming Nrf2/Hmox1 pathway dependence. Our finding indicated that COR inhibits ferroptosis via activation of the Nrf2/Hmox1 signaling pathway, thereby attenuating renal injury and fibrosis and slowing AKI‐CKD progression.
SN - 0263-6484
SN - 1099-0844
ER -